Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...

Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving ...

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...